• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021.

作者信息

Lindboe Johanne Bjerre, Brynskov Troels, Sørensen Torben Lykke, Schmidt Laugesen Caroline

机构信息

Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.

Department of Ophthalmology, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark.

出版信息

Acta Ophthalmol. 2024 Jun;102(4):e661-e662. doi: 10.1111/aos.16677. Epub 2024 Mar 25.

DOI:10.1111/aos.16677
PMID:38525896
Abstract
摘要

相似文献

1
Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021.2008年至2021年雷珠单抗和阿柏西普玻璃体内注射治疗糖尿病性黄斑水肿的真实世界经验
Acta Ophthalmol. 2024 Jun;102(4):e661-e662. doi: 10.1111/aos.16677. Epub 2024 Mar 25.
2
Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.玻璃体内注射阿柏西普治疗糖尿病性黄斑水肿：摩尔费尔德眼科医院的12个月真实世界视力及解剖学结果
Eur J Ophthalmol. 2020 May;30(3):557-562. doi: 10.1177/1120672119833270. Epub 2019 Feb 26.
3
IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.长期玻璃体内抗血管内皮生长因子治疗对糖尿病性黄斑水肿中预先存在的微观结构改变的影响。
Retina. 2018 Sep;38(9):1824-1829. doi: 10.1097/IAE.0000000000001788.
4
Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience.比较雷珠单抗、阿柏西普和地塞米松植入物单药治疗初治糖尿病黄斑水肿眼：12 个月的真实体验。
Indian J Ophthalmol. 2024 May 1;72(Suppl 3):S453-S458. doi: 10.4103/IJO.IJO_2310_23. Epub 2024 Mar 8.
5
Similar real-world two-year visual acuity gains in treatment-naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti-vascular endothelial growth factor.在初治糖尿病性黄斑水肿患者中，与玻璃体腔内抗血管内皮生长因子的较不强化治疗方案相比，采用初始每月注射三次的负荷剂量治疗，两年时的视力在现实世界中的改善情况相似。
Acta Ophthalmol. 2021 Nov;99(7):e1248-e1249. doi: 10.1111/aos.14724. Epub 2021 May 6.
6
Three-month outcomes of ziv-aflibercept in the treatment of diabetic macular oedema.阿柏西普治疗糖尿病性黄斑水肿的三个月疗效
Acta Ophthalmol. 2016 Nov;94(7):e669. doi: 10.1111/aos.13111. Epub 2016 May 26.
7
Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness.阿柏西普用于曾接受雷珠单抗和/或贝伐单抗治疗的糖尿病性黄斑水肿眼，可能会进一步改善黄斑厚度。
Ophthalmic Surg Lasers Imaging Retina. 2016 Sep 1;47(9):836-9. doi: 10.3928/23258160-20160901-06.
8
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.雷珠单抗或阿柏西普治疗糖尿病性黄斑水肿：抗视网膜病变！注册研究的 1 年结局比较。
Ophthalmology. 2020 May;127(5):608-615. doi: 10.1016/j.ophtha.2019.11.018. Epub 2019 Nov 26.
9
Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.在对贝伐单抗无反应的糖尿病性黄斑水肿病例中早期改用雷珠单抗或阿柏西普的短期效果
Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):230-236. doi: 10.3928/23258160-20170301-06.
10
Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept.玻璃体内注射阿柏西普治疗对贝伐单抗或雷珠单抗耐药的糖尿病性黄斑水肿患者：对阿柏西普反应的分析
Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):250-255. doi: 10.22608/APO.2016186. Epub 2017 Apr 10.